Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database
Background: Glioblastoma (GBM) is the most common primary intracranial malignancy. Previous studies found incidence of GBM varies substantially by age, sex, race and ethnicity, and survival also varies by country, ethnicity, and treatment. Gliosarcoma (GSM) and giant cell glioblastoma (GC-GBM) are d...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65b20fc09c354a168ca63446b3744603 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:65b20fc09c354a168ca63446b3744603 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:65b20fc09c354a168ca63446b37446032021-11-30T15:36:24ZEpidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database1664-229510.3389/fneur.2021.659921https://doaj.org/article/65b20fc09c354a168ca63446b37446032021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.659921/fullhttps://doaj.org/toc/1664-2295Background: Glioblastoma (GBM) is the most common primary intracranial malignancy. Previous studies found incidence of GBM varies substantially by age, sex, race and ethnicity, and survival also varies by country, ethnicity, and treatment. Gliosarcoma (GSM) and giant cell glioblastoma (GC-GBM) are different histologic variants of GBM with distinct clinico-pathologic entities. We conducted a study to compare epidemiology, survival, and prognostic factors among the three.Methods: We identified GBM patients diagnosed between 2000 and 2016 using the Taiwan Cancer Registry and followed them using the death registry. Survival was compared among conventional GBM and two histologic variants. The potential confounding factors evaluated in this study included registered year, age, sex, and treatment modality (resection, radiotherapy, and chemotherapy).Results: We enrolled 3,895 patients, including 3,732 (95.8%) with conventional GBM, 102 (2.6%) with GSM, and 61 (1.6%) with GC-GBM. GC-GBM patients had younger mean age at diagnosis (49.5 years) than conventional GBM patients (58.7 years) and GSM patients (61.3 years) (p < 0.01). The three groups had similar sex distributions (p = 0.29). GC-GBM had a longer median survival [18.5, 95% confidence interval (CI): 15.8–25.3 months] than conventional GBM (12.5, 95%CI: 12.0–13.0 months) and GSM (12.8, 95%CI: 9.2–16.2 months), and the differences in overall survival did not attain statistical significance (p = 0.08, log-rank test). In univariate analysis, GC-GBM had better survival than conventional GBM, but the hazard ratio (0.91) did not reach statistical significance (95%CI: 0.69–1.20) in the multivariate analysis. Young ages (≤ 40 years), female sex, resection, radiotherapy, and chemotherapy were factors associated with better survival in overall GBMs. In subtype analyses, these factors remained statistically significant for conventional GBM, as well as radiotherapy for GSM.Conclusion: Our analysis found conventional GBM and its variants shared similar poor survival. Factors with age ≤ 40 years, female sex, resection, radiotherapy, and chemotherapy were associated with better prognosis in conventional GBM patients.Li-Tsun ShiehChung-Han HoChung-Han HoHow-Ran GuoHow-Ran GuoChien-Cheng HuangChien-Cheng HuangYi-Chia HoSheng-Yow HoSheng-Yow HoSheng-Yow HoFrontiers Media S.A.articleglioblastomagliosarcomagiant cell glioblastomahistologic variantepidemiologyNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
glioblastoma gliosarcoma giant cell glioblastoma histologic variant epidemiology Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
glioblastoma gliosarcoma giant cell glioblastoma histologic variant epidemiology Neurology. Diseases of the nervous system RC346-429 Li-Tsun Shieh Chung-Han Ho Chung-Han Ho How-Ran Guo How-Ran Guo Chien-Cheng Huang Chien-Cheng Huang Yi-Chia Ho Sheng-Yow Ho Sheng-Yow Ho Sheng-Yow Ho Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database |
description |
Background: Glioblastoma (GBM) is the most common primary intracranial malignancy. Previous studies found incidence of GBM varies substantially by age, sex, race and ethnicity, and survival also varies by country, ethnicity, and treatment. Gliosarcoma (GSM) and giant cell glioblastoma (GC-GBM) are different histologic variants of GBM with distinct clinico-pathologic entities. We conducted a study to compare epidemiology, survival, and prognostic factors among the three.Methods: We identified GBM patients diagnosed between 2000 and 2016 using the Taiwan Cancer Registry and followed them using the death registry. Survival was compared among conventional GBM and two histologic variants. The potential confounding factors evaluated in this study included registered year, age, sex, and treatment modality (resection, radiotherapy, and chemotherapy).Results: We enrolled 3,895 patients, including 3,732 (95.8%) with conventional GBM, 102 (2.6%) with GSM, and 61 (1.6%) with GC-GBM. GC-GBM patients had younger mean age at diagnosis (49.5 years) than conventional GBM patients (58.7 years) and GSM patients (61.3 years) (p < 0.01). The three groups had similar sex distributions (p = 0.29). GC-GBM had a longer median survival [18.5, 95% confidence interval (CI): 15.8–25.3 months] than conventional GBM (12.5, 95%CI: 12.0–13.0 months) and GSM (12.8, 95%CI: 9.2–16.2 months), and the differences in overall survival did not attain statistical significance (p = 0.08, log-rank test). In univariate analysis, GC-GBM had better survival than conventional GBM, but the hazard ratio (0.91) did not reach statistical significance (95%CI: 0.69–1.20) in the multivariate analysis. Young ages (≤ 40 years), female sex, resection, radiotherapy, and chemotherapy were factors associated with better survival in overall GBMs. In subtype analyses, these factors remained statistically significant for conventional GBM, as well as radiotherapy for GSM.Conclusion: Our analysis found conventional GBM and its variants shared similar poor survival. Factors with age ≤ 40 years, female sex, resection, radiotherapy, and chemotherapy were associated with better prognosis in conventional GBM patients. |
format |
article |
author |
Li-Tsun Shieh Chung-Han Ho Chung-Han Ho How-Ran Guo How-Ran Guo Chien-Cheng Huang Chien-Cheng Huang Yi-Chia Ho Sheng-Yow Ho Sheng-Yow Ho Sheng-Yow Ho |
author_facet |
Li-Tsun Shieh Chung-Han Ho Chung-Han Ho How-Ran Guo How-Ran Guo Chien-Cheng Huang Chien-Cheng Huang Yi-Chia Ho Sheng-Yow Ho Sheng-Yow Ho Sheng-Yow Ho |
author_sort |
Li-Tsun Shieh |
title |
Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database |
title_short |
Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database |
title_full |
Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database |
title_fullStr |
Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database |
title_full_unstemmed |
Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database |
title_sort |
epidemiologic features, survival, and prognostic factors among patients with different histologic variants of glioblastoma: analysis of a nationwide database |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/65b20fc09c354a168ca63446b3744603 |
work_keys_str_mv |
AT litsunshieh epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT chunghanho epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT chunghanho epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT howranguo epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT howranguo epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT chienchenghuang epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT chienchenghuang epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT yichiaho epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT shengyowho epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT shengyowho epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase AT shengyowho epidemiologicfeaturessurvivalandprognosticfactorsamongpatientswithdifferenthistologicvariantsofglioblastomaanalysisofanationwidedatabase |
_version_ |
1718406508721471488 |